Anavex Life Sciences (AVXL) Cash from Financing Activities (2010 - 2026)
Anavex Life Sciences' Cash from Financing Activities came in at $113,000 for fiscal Q2 2026 (quarter ended Mar 31, 2026), down 86.7% from $852,000 a year earlier and down 99.7% from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Cash from Financing Activities (2010 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Cash from Financing Activities was $9.43 million, down 21.2% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of -19.8% (FY2020 to FY2025).
- Going back by fiscal year, Cash from Financing Activities was $11.98 million in FY2024 (-59.6%), $29.65 million in FY2023 (+39.3%), $21.29 million in FY2022 (-86.1%) and $153.24 million in FY2021 (+440.5%).
- The five-year range for quarterly Cash from Financing Activities is -$2.14 million (fiscal Q3 2025) to $89.22 million (fiscal Q3 2021).
- The fastest year-over-year change in Cash from Financing Activities over five years came in fiscal Q2 2023 (growth of 54.9%), and the weakest in fiscal Q4 2022 (a decline of 99.9%).
- Business Quant data shows AVXL's Cash from Financing Activities at $36.32 million (Q1 2026), $10.02 million (Q4 2025) and -$2.14 million (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -47.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Anavex Life Sciences | 175.20 Mn | -304.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 113,000.00 |
| Dec 31, 2025 | 36.32 Mn |
| Sep 30, 2025 | 10.02 Mn |
| Jun 30, 2025 | -2.14 Mn |
| Mar 31, 2025 | 852,000.00 |
| Dec 31, 2024 | 708,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 4.55 Mn |
| Mar 31, 2024 | 7.28 Mn |
| Dec 31, 2023 | 59,000.00 |
| Sep 30, 2023 | 2.06 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 18.33 Mn |
| Dec 31, 2022 | 258,000.00 |
| Sep 30, 2022 | 2,464.00 |
| Jun 30, 2022 | 6.91 Mn |
| Mar 31, 2022 | 11.84 Mn |
| Dec 31, 2021 | 2.54 Mn |
| Sep 30, 2021 | 2.22 Mn |
| Jun 30, 2021 | 89.22 Mn |
API Access
Anavex Life Sciences Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();